1326 related articles for article (PubMed ID: 18291561)
1. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
[TBL] [Abstract][Full Text] [Related]
2. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
3. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
5. Development and use of fowlpox vectored vaccines for avian influenza.
Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
[TBL] [Abstract][Full Text] [Related]
6. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.
Pavlova SP; Veits J; Mettenleiter TC; Fuchs W
Vaccine; 2009 Aug; 27(37):5085-90. PubMed ID: 19573638
[TBL] [Abstract][Full Text] [Related]
7. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
8. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.
Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K
Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840
[TBL] [Abstract][Full Text] [Related]
9. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
Jiang Y; Yu K; Zhang H; Zhang P; Li C; Tian G; Li Y; Wang X; Ge J; Bu Z; Chen H
Antiviral Res; 2007 Sep; 75(3):234-41. PubMed ID: 17451817
[TBL] [Abstract][Full Text] [Related]
10. Comparison of single 1-day-old chick vaccination using a Newcastle disease virus vector with a prime/boost vaccination scheme against a highly pathogenic avian influenza H5N1 challenge.
Ferreira HL; Rauw F; Pirlot JF; Reynard F; van den Berg T; Bublot M; Lambrecht B
Avian Pathol; 2014; 43(1):68-77. PubMed ID: 24320551
[TBL] [Abstract][Full Text] [Related]
11. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.
Isoda N; Sakoda Y; Kishida N; Soda K; Sakabe S; Sakamoto R; Imamura T; Sakaguchi M; Sasaki T; Kokumai N; Ohgitani T; Saijo K; Sawata A; Hagiwara J; Lin Z; Kida H
Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks.
Middleton D; Bingham J; Selleck P; Lowther S; Gleeson L; Lehrbach P; Robinson S; Rodenberg J; Kumar M; Andrew M
Virology; 2007 Mar; 359(1):66-71. PubMed ID: 17028058
[TBL] [Abstract][Full Text] [Related]
13. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus.
Swayne DE; Lee CW; Spackman E
Avian Pathol; 2006 Apr; 35(2):141-6. PubMed ID: 16595307
[TBL] [Abstract][Full Text] [Related]
14. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza.
Swayne DE
Ann N Y Acad Sci; 2006 Oct; 1081():174-81. PubMed ID: 17135509
[TBL] [Abstract][Full Text] [Related]
15. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
16. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
Niqueux E; Guionie O; Amelot M; Jestin V
Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
[TBL] [Abstract][Full Text] [Related]
18. Vaccines developed for H5 highly pathogenic avian influenza in China.
Qiao C; Tian G; Jiang Y; Li Y; Shi J; Yu K; Chen H
Ann N Y Acad Sci; 2006 Oct; 1081():182-92. PubMed ID: 17135510
[TBL] [Abstract][Full Text] [Related]
19. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza.
Veits J; Wiesner D; Fuchs W; Hoffmann B; Granzow H; Starick E; Mundt E; Schirrmeier H; Mebatsion T; Mettenleiter TC; Römer-Oberdörfer A
Proc Natl Acad Sci U S A; 2006 May; 103(21):8197-202. PubMed ID: 16717197
[TBL] [Abstract][Full Text] [Related]
20. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus.
Sasaki T; Kokumai N; Ohgitani T; Sakamoto R; Takikawa N; Lin Z; Okamatsu M; Sakoda Y; Kida H
Vaccine; 2009 Aug; 27(38):5174-7. PubMed ID: 19596414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
